Cargando…
EE240 Estimating the COVID-19 Cost-of-Illness Associated with Comorbidities in a Brazilian Public Hospital
Autores principales: | Oliveira, LA, Lucchetta, R, Tonin, F, Bonetti, AF, Borba, HH, Matoso Mendes, A, Rossignoli, P, Virtuoso, S, Wiens, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232708/ http://dx.doi.org/10.1016/j.jval.2022.04.488 |
Ejemplares similares
-
Cost of Illness in Patients With COVID-19 Admitted in Three Brazilian Public Hospitals
por: Oliveira, Layssa Andrade, et al.
Publicado: (2023) -
Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: a multicenter longitudinal study
por: Borba, Helena HL, et al.
Publicado: (2017) -
EE240 Beyond Symptoms Alleviation: Population-Level Benefits of COVID-19 Oral Direct-Acting Antiviral (DAA) Treatment and Resulting Decreases in Infectivity and Transmission
por: Chacon-Araya, M., et al.
Publicado: (2023) -
Description of network meta-analysis geometry: A metrics design study
por: Tonin, Fernanda S., et al.
Publicado: (2019) -
EE483 The Economic Impact of Coronavirus Pandemic on Stroke Care: Direct and Indirect Costs Estimations in Chile
por: Paredes, D, et al.
Publicado: (2022)